Johnson & Johnson reported orthopedic sales in the U.S. were down 5.2 percent in the first quarter and all subspecialty lines reported drops as well due to the coronavirus.
Spinal Tech
Here are eight key notes on spine and orthopedic device companies:
The FDA approved Centinel Spine's prodisc L lumbar total disc replacement device for two-level indications on April 14.
Biotechnology company Vomaris plans to expedite the approval of its bioelectric V.Dox system after research has indicated that viruses are killed upon exposure to the technology, the Daily Independent reports.
More than 1.2 million spinal surgeries are performed in the U.S. each year, including spinal fusion, decompression and discectomy procedures, according to the National Center for Health Statistics. And the volume of elective lumbar fusions is rising across the U.S.,…
Advertisement
NuVasive is reducing executive and board member compensation and taking other temporary cost-cutting measures during the COVID-19 pandemic, which has significantly lowered elective procedure volumes.
Johnson & Johnson subsidiary Ethicon is scrapping plans to buy Takeda Pharmaceutical's TachoSil surgical patch for controlling bleeding, Reuters reports.
Axis Spine received $1 million (830,000 pounds) from three investors as it readies to advance its anterior spinal implant technology in the U.S., Business Leader reports.
The FDA on April 14 granted TDi 510(k) clearance for its SonoVision ultrasound system for spine surgery.
Biotechnology company CytoDyn told investors on April 13 that five patients with mild-to-moderate COVID-19 symptoms were able to get off oxygen after taking its leronlimab drug, Proactive Investors reports.